Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Evaxion A/S

Market Cap 3.01Cr 2.6Cr 2.4Cr 2.24Cr 4.2Cr 286.18Cr 4.27Cr 28Cr 11Cr 139.29Cr 11Cr 11Cr 482.31Cr P/E Ratio 2026 *
-90.3x
P/E Ratio 2027 * 90.3x
Enterprise Value 3.01Cr 2.6Cr 2.4Cr 2.24Cr 4.2Cr 286.18Cr 4.27Cr 28Cr 11Cr 139.29Cr 11Cr 11Cr 482.31Cr EV / Sales 2026 *
-
EV / Sales 2027 * 1.78x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day+1.39%
1 week+3.10%
Current month-8.50%
1 month-12.23%
3 months-12.44%
6 months-41.06%
Current year-23.27%
1 week 3.5
Extreme 3.5
3.96
1 month 3.42
Extreme 3.4201
4.35
Current year 2.87
Extreme 2.871
5.48
1 year 2.07
Extreme 2.07
12.15
3 years 1.2
Extreme 1.2
69.1
5 years 1.2
Extreme 1.2
1,252
10 years 1.2
Extreme 1.2
1,252
Manager TitleAgeSince
Chief Executive Officer 59 24/11/2025
Corporate Officer/Principal 49 11/08/2008
Director of Finance/CFO 53 01/11/2024
Director TitleAgeSince
Chairman 58 25/11/2020
Director/Board Member 56 01/01/2018
Director/Board Member 68 25/05/2021
Date Insider Type Main position Quantity % Market Cap.
16/04Other

Director

2,376 0.0006%
18/03Other

Founder

64,17,013 1.5388%
18/03Other

Director

1,29,139 0.0310%
Change 5-day change 1-year change 3-year change Capi.($)
+1.39%+3.10%+23.23%-94.43% 3.01Cr
-0.35%+0.97%-15.96%-12.73% 4.3TCr
+2.97%+2.88%+273.45%+506.58% 3.17TCr
-1.23%-2.21%+12.73%-15.34% 3.02TCr
+1.59%-2.16%-4.43%+23.95% 2.89TCr
+4.09%-1.98%+11.99%+17.37% 2.39TCr
-1.84%+3.26%+54.30%+115.15% 1.36TCr
-0.40%-1.29%+6.06%+7.59% 1.3TCr
+2.59%+5.33% - - 1.34TCr
-1.06%-1.95%+105.01%+75.41% 1.22TCr
Average +0.76%-1.31%+51.82%+69.28% 2.1TCr
Weighted average by Cap. +0.81%-1.08%+54.11%+95.42%

Financials

2026 *2027 *
Net sales - 1.69Cr 1.46Cr 1.35Cr 1.26Cr 2.37Cr 161.09Cr 2.4Cr 16Cr 6.21Cr 78Cr 6.36Cr 6.23Cr 271.5Cr
Net income -1.58Cr -1.36Cr -1.26Cr -1.18Cr -2.2Cr -150.02Cr -2.24Cr -15Cr -5.78Cr -73Cr -5.92Cr -5.8Cr -252.84Cr -11.15L -10L -9L -8L -15.57L -11Cr -15.81L -1.05Cr -40.86L -5.16Cr -41.86L -40.96L -18Cr
Net Debt - -
Logo Evaxion A/S
Evaxion A/S, formerly known as Evaxion Biotech A/S, is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
Employees
46
Date Price Change Volume
12/26/12 3.660 $ +1.39% 41,723
11/26/11 3.610 $ -4.75% 16,391
10/26/10 3.790 $ +4.41% 24,995
09/26/09 3.630 $ -2.68% 28,300
08/26/08 3.730 $ +5.07% 20,292
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.610USD
Average target price
11.25USD
Spread / Average Target
+211.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVAX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!